A possible role for GRP78 in cross vaccination against COVID-19

J Infect. 2021 Feb;82(2):282-327. doi: 10.1016/j.jinf.2020.09.004. Epub 2020 Sep 10.

Authors

Abdo A Elfiky¹, Ibrahim M Ibrahim², Alaa M Ismail², Wael M Elshemey³

Affiliations

¹ Biophysics Department, Faculty of Sciences, Cairo University, Giza, Egypt. Electronic address: abdo@sci.cu.edu.eg.
² Biophysics Department, Faculty of Sciences, Cairo University, Giza, Egypt.
³ Biophysics Department, Faculty of Sciences, Cairo University, Giza, Egypt; Department of physics, Faculty of Science, Islamic University in Madinah, KSA, Saudi Arabia.

No abstract available

Publication types

Letter
Comment

MeSH terms

Binding Sites
COVID-19*
Carrier Proteins
Endoplasmic Reticulum Chaperone BiP
Humans
SARS-CoV-2
Vaccination

Substances

Carrier Proteins
Endoplasmic Reticulum Chaperone BiP
HSPA5 protein, human